Therapeutic options and treatment of muscle invasive bladder cancer. Expert Rev Anticancer Ther 2001 Dec;1(4):511-22
Date
07/13/2002Pubmed ID
12113083DOI
10.1586/14737140.1.4.511Scopus ID
2-s2.0-0035558069 (requires institutional sign-in at Scopus site) 7 CitationsAbstract
Carcinoma of the bladder is the second most common genitourinary malignancy. Although several treatments exist, the gold standard therapy for muscle invasive bladder cancer (> or = stage T2) is cystectomy with urinary diversion. We review various surgical treatments for muscle invasive bladder cancer, focusing on the reported survival rates, complications, advantages and disadvantages of each therapeutic modality.
Author List
O'Connor RC, Alsikafi NF, Steinberg GDAuthor
Robert Corey O'Connor MD Professor in the Urologic Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Chemotherapy, AdjuvantCystectomy
Humans
Muscle Neoplasms
Neoadjuvant Therapy
Neoplasm Invasiveness
Radiotherapy, Adjuvant
Survival Rate
Treatment Outcome
Urinary Bladder Neoplasms
Urinary Diversion